Study Evaluating Levonorgestrel and Ethinyl Estradiol for Oral Contraception
NCT00245921
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
2000
Enrollment
INDUSTRY
Sponsor class
Conditions
Contraception
Interventions
DRUG:
Levonorgestrel 90 mg/Ethinyl Estradiol 20 mg
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer